May. 8 at 1:35 PM
$ANNX Good remark in earnings release. States they have Real World Evidence data positively affecting GBS. To my recollection, with the FDA they only needed a little bit of this data, like showing 1 week. I don't know how much they have, but during his Conference with Needham, the order of events for the year has FDA BLM submission next. This places that before the Archer II study data during 4th Q. So sometime between now and then. I'm thinking they may be sooner rather than later, depends on when they can get the FDA meeting scheduled.
